Medical Patent News

RSS

Haemonetics alleges continued patent infringement by Fenwal, files a new lawsuit

Haemonetics Corporation announced today that it has filed a new legal action to stop Fenwal Inc.'s continued patent infringement resulting from Fenwal's just released red cell collection kits, using a modified separation chamber. Fenwal allegedly modified its separation chamber to circumvent Haemonetics' patent and the injunction entered by the Court prohibiting Fenwal's continued sale of infringing products after December 1, 2010.

15 Dec 2009

CureDM receives patent allowance for novel islet neogenesis program

CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.

15 Dec 2009

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Geron Corporation today announced that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has granted Geron’s request to declare an interference between a patent application owned by Geron and U.S. Patent No. 7,510,876 (the ‘876 patent) owned by Novocell, Inc.

15 Dec 2009

USPTO issues Notice of Allowance to Transcept Pharmaceuticals for Intermezzo claims

Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/060,641, which covers the composition and use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate.

15 Dec 2009

Sword Diagnostics receives patent on improved sensitivity technology for detection of biological organisms

Sword Diagnostics, Inc. is pleased to announce that the United States Patent Office (USPTO) has issued patent number 7,599,057 titled "Method and Apparatus for Detection of Biological Organisms using Raman Scattering" to the company.

15 Dec 2009

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist’s US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.

14 Dec 2009

USPTO grants CyDex Pharmaceuticals patent for Captisol

CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled “Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof.” This patent, along with other previously issued technology patents, will provide broader protection for CyDex’s Captisol® technology until 2028.

9 Dec 2009

Depression drug TC-5214 earns USF its most lucrative patent royalties to date

A depression drug created and patented by a team of University of South Florida researchers is at the center of major deal between global pharmaceutical company AstraZeneca PLC and Targacept, Inc., earning the university its potentially most lucrative patent royalties to date.

9 Dec 2009

ADHC to acquire stem cell patents for commercial purposes

American Diversified Holdings Corporation has announced, as part of its previously disclosed strategy to concentrate in developing innovative technologies in the life sciences sector, specifically targeting the fast growing stem cell arena, that the Company is actively seeking to acquire stem cell patents for the express purpose of developing these patents for commercial purposes.

9 Dec 2009

AbSorber receives patent protection for its XM-ONE in the European countries

AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product.

8 Dec 2009

EPO grants patent for AbSorber's transplantation cross match-test

LinkMed’s subsidiary AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product. The European countries are highly prioritized markets for AbSorber and the patent approval is an important milestone in Absorbers intellectual property strategy.

8 Dec 2009

Amino acids can improve cognitive function in patients with severe brain injuries

Neurology researchers have shown that feeding amino acids to brain-injured animals restores their cognitive abilities and may set the stage for the first effective treatment for cognitive impairments suffered by people with traumatic brain injuries.

8 Dec 2009

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") announced today that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company's DCVax® therapeutic cancer vaccines.

4 Dec 2009

Smokefree Innotec's Swiss patent and trademark attorneys start nationalizing PCT patent application

Smokefree Innotec, Inc. announced today that its Swiss patent and trademark attorneys Spierenburg & Partners AG have started nationalizing and regionalizing the PCT patent application for SFIO's Real Smokefree product.

4 Dec 2009

Patent titled 'System and Method for 4D Reconstruction and Visualization' receives issuance in Japan

VirtualScopics, Inc., a leading provider of quantitative imaging for clinical trials, announced today that its patent titled "System and Method for 4D Reconstruction and Visualization" recently received issuance in Japan.

4 Dec 2009

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Non-Invasive Monitoring Systems, Inc. announced that the Canadian Patent Office issued Patent number 2,534,302 to NIMS on October 20, 2009. The patent, entitled “Reciprocating Movement Platform for the External Addition of Pulses to the Fluid Channels of a Subject”, relates to the comprehensively researched technology underlying NIMS’ Exer-Rest acceleration therapeutic platform.

3 Dec 2009

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGIL® (armodafinil) Tablets [C-IV].

3 Dec 2009

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled “POU5-F1 Expression in Human Mesenchymal Stem Cells” and the development of new technology related to generation of human induced pluripotent stem cells (iPS).

2 Dec 2009

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440, titled "Cyclic Natriuretic Peptide Constructs." The claims in the issued patent cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate.

1 Dec 2009

Kemin Foods, OmniActive settle patent dispute

Kemin Foods, L.C. ("Kemin") and OmniActive Health Technologies, Inc. and OmniActive Health Technologies, Ltd. ("OmniActive") have reached an amicable settlement of their dispute.

1 Dec 2009

Medical Patent News

Haemonetics alleges continued patent infringement by Fenwal, files a new lawsuit

CureDM receives patent allowance for novel islet neogenesis program

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

USPTO issues Notice of Allowance to Transcept Pharmaceuticals for Intermezzo claims

Sword Diagnostics receives patent on improved sensitivity technology for detection of biological organisms

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

USPTO grants CyDex Pharmaceuticals patent for Captisol

Depression drug TC-5214 earns USF its most lucrative patent royalties to date

ADHC to acquire stem cell patents for commercial purposes

AbSorber receives patent protection for its XM-ONE in the European countries

EPO grants patent for AbSorber's transplantation cross match-test

Amino acids can improve cognitive function in patients with severe brain injuries

DCVax therapeutic cancer vaccine manufacturing process receives patent approval

Smokefree Innotec's Swiss patent and trademark attorneys start nationalizing PCT patent application

Patent titled 'System and Method for 4D Reconstruction and Visualization' receives issuance in Japan

NIMS’ Exer-Rest acceleration therapeutic platform granted Canadian Patent

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

Kemin Foods, OmniActive settle patent dispute

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News